Merck Warns Shareholders Against Unsolicited Mini-Tender Offer from Tutanota LLC.
ByAinvest
Friday, Nov 21, 2025 11:10 pm ET1min read
MRK--
Merck & Co. has urged shareholders to reject an unsolicited mini-tender offer from Tutanota LLC to purchase up to 1 million shares at $65.00, which is 24.66% below the closing price of $86.28 on November 7, 2025. The offer is subject to several conditions and is priced significantly below the current market value of Merck's stock. Merck emphasizes that it is not associated with Tutanota or its mini-tender offer and advises shareholders to refrain from tendering their shares.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet